Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Results presented at ASTMH demonstrate safety and efficacy of tafenoquine in malaria

Dec. 2, 1999

Bayer's CMV product advances to phase II

Dec. 2, 1999

ASTMH news: PS-22, a new antimalarial prodrug, tested for toxicity

Dec. 2, 1999

Lilly presents modified glycopeptides with antibacterial activity

Dec. 2, 1999

Combinations of imidazoles for female genital infections

Dec. 1, 1999

Sankyo presents new antifungal agent at Japanese symposium

Dec. 1, 1999

New lobucavir prodrug and its quantitative determination along with active compound in plasma

Nov. 30, 1999

Helix describes novel antimicrobial therapeutics particularly for Candida and Pseudomonas infections

Nov. 30, 1999

D-0870-loaded nanospheres highly effective in mouse model of Chagas' disease

Nov. 29, 1999

Lack of PK interaction between Ziracin and gentamicin demonstrated in humans

Nov. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...